Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Cordero-Coma

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Ocular Immunology and Inflammation|June 15, 2007
Systemic immunomodulatory therapy in severe dry eye secondary to inflammationMiguel Cordero-Coma, Fahd Anzaar, Lucia Sobrin, et al.
Herpes : the Journal of the IHMF|September 13, 2007
Herpetic retinitisMiguel Cordero-Coma, Fahd Anzaar, Taygan Yilmaz, et al.
Expert Opinion on Drug Safety|October 18, 2014
Drug-induced uveitisMiguel Cordero-Coma, Raquel Salazar-Méndez, Irene Garzo-García, et al.
Acta Ophthalmologica|July 22, 2010
Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedemaTaygan Yilmaz, Miguel Cordero-Coma, Michéal J Gallagher, et al.
Indian Journal of Ophthalmology|November 27, 2021
The application of the retraction watch database in eye research-based studiesAndrew T Barton, Miguel Cordero-Coma, Micheal J Gallagher, et al.
Ophthalmology|March 17, 2007
Intravitreal bevacizumab for treatment of uveitic macular edemaMiguel Cordero Coma, Lucia Sobrin, Sumru Onal, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 9, 2010
Statistical process control charts for ophthalmologyMiguel Cordero-Coma, Taygan Yilmaz, William V Padula, et al.
Ophthalmology|September 6, 2011
Golimumab for uveitisMiguel Cordero-Coma, David Salom, Manuel Díaz-Llopis, et al.
Current Pharmaceutical Biotechnology|October 14, 2010
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathyTaygan Yilmaz, Miguel Cordero-Coma, Alejandro J Lavaque, et al.
Ocular Immunology and Inflammation|April 27, 2013
Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responsesMiguel Cordero-Coma, Sara Calleja, Milagros Llorente, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Ocular Immunology and Inflammation|June 15, 2007
Systemic immunomodulatory therapy in severe dry eye secondary to inflammationMiguel Cordero-Coma, Fahd Anzaar, Lucia Sobrin, et al.
Herpes : the Journal of the IHMF|September 13, 2007
Herpetic retinitisMiguel Cordero-Coma, Fahd Anzaar, Taygan Yilmaz, et al.
Expert Opinion on Drug Safety|October 18, 2014
Drug-induced uveitisMiguel Cordero-Coma, Raquel Salazar-Méndez, Irene Garzo-García, et al.
Acta Ophthalmologica|July 22, 2010
Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedemaTaygan Yilmaz, Miguel Cordero-Coma, Michéal J Gallagher, et al.
Indian Journal of Ophthalmology|November 27, 2021
The application of the retraction watch database in eye research-based studiesAndrew T Barton, Miguel Cordero-Coma, Micheal J Gallagher, et al.
Ophthalmology|March 17, 2007
Intravitreal bevacizumab for treatment of uveitic macular edemaMiguel Cordero Coma, Lucia Sobrin, Sumru Onal, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 9, 2010
Statistical process control charts for ophthalmologyMiguel Cordero-Coma, Taygan Yilmaz, William V Padula, et al.
Ophthalmology|September 6, 2011
Golimumab for uveitisMiguel Cordero-Coma, David Salom, Manuel Díaz-Llopis, et al.
Current Pharmaceutical Biotechnology|October 14, 2010
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathyTaygan Yilmaz, Miguel Cordero-Coma, Alejandro J Lavaque, et al.
Ocular Immunology and Inflammation|April 27, 2013
Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responsesMiguel Cordero-Coma, Sara Calleja, Milagros Llorente, et al.
Pageof 8